Pilar Garrido
- Oncology top 1%
- Lung Cancer Research Studies 62
- Cancer Immunotherapy and Biomarkers 50
- Colorectal Cancer Treatments and Studies 25
-
- Lung Cancer Treatments and Mutations 153
- Lung Cancer Diagnosis and Treatment 68
- Gastric Cancer Management and Outcomes 17
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 36
- Molecular Biology top 10%
- Cancer therapeutics and mechanisms 19
- Co-authors
- Dolores IslaLuis Paz‐AresEnriqueta FelipJavier de CastroLucio CrinòC. AvendañoJosé Antonio SacristánÉric Dansin
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Pilar Garrido
265 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Oncology 2.1k
- Pulmonary and Respiratory Medicine 1.9k
- Cancer Research 610
- Pathology and Forensic Medicine 302
- Molecular Biology 909
Countries citing papers authored by Pilar Garrido
This map shows the geographic impact of Pilar Garrido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pilar Garrido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pilar Garrido more than expected).
Fields of papers citing papers by Pilar Garrido
This network shows the impact of papers produced by Pilar Garrido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pilar Garrido. The network helps show where Pilar Garrido may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pilar Garrido, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 8 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 23 | |
| 10 | 2022 | 0 | |
| 11 | 2022 | 25 | |
| 12 | 2021 | 0 | |
| 13 | 2021 | 11 | |
| 14 | 2020 | 31 | |
| 15 | 2019 | 23 | |
| 16 | 2019 | 19 | |
| 17 | 2018 | 17 | |
| 18 | 2017 | 4 | |
| 19 | 2017 | 4 | |
| 20 | Pseudotuberculosis en Andalucía: actualización del diagnóstico laboratorial | 2013 | 1 |
About Pilar Garrido
Pilar Garrido is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 291 papers that have together received 3.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (153 papers), Lung Cancer Diagnosis and Treatment (68 papers), Lung Cancer Research Studies (62 papers), Cancer Immunotherapy and Biomarkers (50 papers), Cancer Genomics and Diagnostics (36 papers), Colorectal Cancer Treatments and Studies (25 papers), Cancer therapeutics and mechanisms (19 papers) and Gastric Cancer Management and Outcomes (17 papers). The work is most often cited by research in Oncology (2.1k citations), Pulmonary and Respiratory Medicine (1.9k citations) and Cancer Research (610 citations). Pilar Garrido has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Dolores Isla, Luis Paz‐Ares, Enriqueta Felip, Javier de Castro, Lucio Crinò, C. Avendaño, José Antonio Sacristán, Éric Dansin, Juan Blanco and Angeles Flores. Their work appears in journals such as JAMA, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.